Tags: Drug.
Erlizumab also known as rhuMAb is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. Erlizumab was developed by Genentech under a partnership with Roche to treat heart attack stroke and traumatic shock.
Loading...
This page contains content from the copyrighted Wikipedia article "Erlizumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.